Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

DBTX

Decibel Therapeutics (DBTX)

Decibel Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DBTX
DatumZeitQuelleÜberschriftSymbolFirma
10/10/202322h56Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:DBTXDecibel Therapeutics Inc
25/09/202322h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202322h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202322h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202315h09Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202315h06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202315h03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202315h00Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314h53Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
12/09/202322h12Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
08/09/202322h23Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
25/08/202315h17Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DBTXDecibel Therapeutics Inc
25/08/202313h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202313h45GlobeNewswire Inc.Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202313h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DBTXDecibel Therapeutics Inc
09/08/202322h55Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202315h34Dow Jones NewsDecibel Therapeutics Shares Surge on Regeneron AcquisitionNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202314h14Dow Jones NewsRegeneron To Acquire Decibel TherapeuticsNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202314h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202313h30GlobeNewswire Inc.Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss ProgramsNASDAQ:DBTXDecibel Therapeutics Inc
14/06/202322h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
14/06/202322h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
14/06/202322h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
13/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DBTXDecibel Therapeutics Inc
02/06/202313h00GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare ConferenceNASDAQ:DBTXDecibel Therapeutics Inc
01/06/202322h30GlobeNewswire Inc.Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:DBTXDecibel Therapeutics Inc
17/05/202322h30GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy SummitNASDAQ:DBTXDecibel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DBTX